CME Group (NASDAQ:CME) Shares Gap Down – Here’s What Happened
by Jessica Moore · The Cerbat GemCME Group Inc. (NASDAQ:CME – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $284.40, but opened at $275.06. CME Group shares last traded at $279.25, with a volume of 841,531 shares.
CME Group News Summary
Here are the key news stories impacting CME Group this week:
- Positive Sentiment: CME reported a strong Q1 with record trading volumes, revenue strength and an EPS beat (management pointed to rising market risk driving hedging demand). This is the main fundamental driver supporting the stock. Record Q1 Revenue
- Positive Sentiment: Morgan Stanley retained an overweight rating and trimmed its price target to $353 (still implying ~23% upside), signaling continued analyst confidence from some large brokers. Morgan Stanley PT
- Neutral Sentiment: Deutsche Bank lowered its price target to $322 but kept a buy rating, leaving a mid‑teens upside while reducing its near‑term upside expectation. Deutsche Bank PT
- Neutral Sentiment: TD Cowen also trimmed its target to $323 but maintained a buy rating, another example of analysts recalibrating upside while remaining constructive. TD Cowen PT
- Neutral Sentiment: Full earnings call transcript and summaries have been posted, offering management color on volume drivers, product mix and margin outlook—useful for investors wanting detail beyond headlines. Earnings Call Transcript
- Negative Sentiment: Goldman Sachs cut its price target to $267 and maintained a sell rating, signaling downside risk and contributing to bearish press flow. Goldman Sachs PT
- Negative Sentiment: Some coverage highlighted mixed reads on the quarter—while volumes and EPS looked strong, a few outlets flagged revenue/sales comparisons and valuation concerns (reports that the stock still looks expensive). That mixed narrative can pressure sentiment despite the operational beat. Earnings Highlights Valuation Concerns
Analyst Upgrades and Downgrades
CME has been the subject of several analyst reports. UBS Group reissued a “neutral” rating and issued a $310.00 target price on shares of CME Group in a research note on Friday, February 6th. Raymond James Financial increased their price target on shares of CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a research note on Monday, April 6th. Keefe, Bruyette & Woods initiated coverage on shares of CME Group in a research report on Wednesday, April 8th. They issued a “market perform” rating and a $305.00 price objective for the company. Morgan Stanley lowered their price objective on shares of CME Group from $362.00 to $353.00 and set an “overweight” rating on the stock in a research note on Thursday. Finally, Barclays cut their target price on shares of CME Group from $343.00 to $316.00 and set an “equal weight” rating for the company in a research note on Thursday. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $306.71.
View Our Latest Analysis on CME Group
CME Group Trading Down 0.1%
The business has a 50 day moving average of $304.87 and a two-hundred day moving average of $285.91. The firm has a market cap of $102.26 billion, a P/E ratio of 24.32, a PEG ratio of 2.91 and a beta of 0.26. The company has a current ratio of 1.02, a quick ratio of 1.03 and a debt-to-equity ratio of 0.13.
CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The firm had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. During the same period in the previous year, the business posted $2.80 earnings per share. The company’s revenue for the quarter was up 14.5% compared to the same quarter last year. Analysts predict that CME Group Inc. will post 12.37 earnings per share for the current year.
CME Group Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, March 26th. Investors of record on Tuesday, March 10th were issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend was Tuesday, March 10th. This is a positive change from CME Group’s previous quarterly dividend of $1.25. CME Group’s payout ratio is presently 46.59%.
Insider Activity at CME Group
In related news, Director Bryan T. Durkin sold 4,200 shares of the company’s stock in a transaction dated Monday, February 23rd. The shares were sold at an average price of $309.65, for a total value of $1,300,530.00. Following the transaction, the director owned 43,007 shares in the company, valued at approximately $13,317,117.55. This represents a 8.90% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Dennis Suskind sold 748 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $300.00, for a total transaction of $224,400.00. Following the sale, the director owned 2,699 shares of the company’s stock, valued at $809,700. This trade represents a 21.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 8,539 shares of company stock worth $2,713,821 in the last quarter. Corporate insiders own 0.30% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Caldwell Trust Co boosted its position in shares of CME Group by 116.3% in the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 50 shares during the period. Asset Dedication LLC increased its position in CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 37 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new stake in CME Group in the 3rd quarter worth about $27,000. FNY Investment Advisers LLC acquired a new stake in CME Group in the 4th quarter worth about $27,000. Finally, Elkhorn Partners Limited Partnership bought a new stake in CME Group in the 4th quarter valued at about $27,000. 87.75% of the stock is owned by institutional investors and hedge funds.
CME Group Company Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.